Celadon Pharmaceuticals (LSE:CEL) Other Long Term Assets : £0.49 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Other Long Term Assets?

Celadon Pharmaceuticals's other long-term assets for the quarter that ended in Jun. 2024 was £0.49 Mil.

Celadon Pharmaceuticals's quarterly other long-term assets declined from Jun. 2023 (£0.22 Mil) to Dec. 2023 (£0.22 Mil) but then increased from Dec. 2023 (£0.22 Mil) to Jun. 2024 (£0.49 Mil).

Celadon Pharmaceuticals's annual other long-term assets increased from Dec. 2021 (£0.00 Mil) to Dec. 2022 (£0.22 Mil) and increased from Dec. 2022 (£0.22 Mil) to Dec. 2023 (£0.22 Mil).

Celadon Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Celadon Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Other Long Term Assets Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

0.22

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long Term Assets	Get a 7-Day Free Trial				0.22	0.22	0.22	0.22	0.49

Celadon Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Celadon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.

Celadon Pharmaceuticals Headlines

No Headlines